Study: Pitocin Doesn’t Lower Risk of Cesarean Section

A British study of the medication pitocin, which is designed to speed up labor and help women avoid Cesarean sections, revealed that though the drug does shorten labor, it does not prevent Cesareans at all. The New York Times reports:

Researchers at Nottingham University Hospitals in England pooled data from eight randomized studies involving 1,338 low-risk women in the first stage of labor. Compared with no treatment, the use of Pitocin shortened labor by about two hours, but it did not reduce the number of Caesarean sections or increase the number of unassisted deliveries.

Giving Pitocin early or late in labor made no difference. It appeared to cause no harm to babies or mothers, but the sample was too small know if it has any effect on the death rates of newborns.

“We need better ways of managing slow progress in labor,” said Dr. George J. Bugg, the lead author and an obstetrician at Nottingham University Hospitals. “It’s a real problem, and the method we’ve relied on for so many years doesn’t actually work.”

The Centers for Disease Control and Prevention reported a Cesarean section rate of 32 percent in 2009.

Add a Comment

Tags: , , | Categories: Pregnancy

Back To Parents News Now
  1. by personal statement

    On December 13, 2011 at 8:28 am

    I really like your blog. I have been researching the topic and will add you to my reader to
    continue reading. Keep up the good work! Others need to know about your site.
    Expert Proofreading at Reasonable Prices

  2. [...] contractions) as a major way to stave off the need for a C-section. Though this is contrary to a British study from two years ago that said the use of pitocin doesn’t lower the risk of a Cesarean [...]

  3. [...] contractions) as a major way to stave off the need for a C-section. Though this is contrary to a British study from two years ago that said the use of pitocin doesn’t lower the risk of a Cesarean section. [...]